ASMB Latest Press Releases

-- October 5, 2026 --

Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting 2026 Globe Newswire 10:00 AM

-- September 10, 2026 --

Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference Globe Newswire 4:15 PM

-- September 8, 2026 --

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program Globe Newswire 4:00 PM

-- August 13, 2026 --

Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates Globe Newswire 4:00 PM

-- May 28, 2026 --

Assembly Biosciences Announces Upcoming Investor Conference Presentations Globe Newswire 4:05 PM

-- May 26, 2026 --

Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares Globe Newswire 4:05 PM

-- May 22, 2026 --

Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants Globe Newswire 7:05 AM

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes